asafd60/LiLT_Processed · Datasets at Hugging Face

id string	words list	boxes list	question string	answer string
544	[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...	[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...	What is the Specific example given?	pioglitazone: need to commit to studies to investigate certain signals
588	[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...	[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...	what is the month and year of overview of submission ?	NOVEMBER 2006
544	[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...	[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...	Which country would have similar interest as in Europe?	usa
588	[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...	[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...	what is included in the summary document ?	includes benefit-risk assessment
544	[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...	[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...	What is the Suggestion from Glyn?	tgrd would formulate direct risk management plan and obtain japan's input
588	[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...	[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...	what is the executive summary of bladder cancer cases ?	CONFIRM
544	[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...	[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...	Full form of PEM?	prescription event monitoring
588	[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...	[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...	what is the name of the request document ?	PARTIAL CLINICAL HOLD REMOVAL REQUEST DOCUMENT
545	[ "PENGAD", "BOO-631-698", "EXHIBIT", "102", "FDA", "Conference", "Call", "on", "July", "31,", "2002", "TPNA", "Personnel:", "Wendell", "Cheatham,", "M.D.", "Vice", "President,", "of", "Medial", "and", "Scientific", "Affairs", "Michael", "Elisseou,", "Ph.D.,", "Dire...	[ [ 814, 80, 828, 107 ], [ 815, 45, 830, 79 ], [ 868, 41, 919, 53 ], [ 874, 63, 928, 88 ], [ 344, 134, 382, 150 ], [ 385, 134, 474, 150 ], [ 478, 135, 510, 150 ], [ 514, ...	On the purpose of teleconference, how many topics were to be discussed?	3
545	[ "PENGAD", "BOO-631-698", "EXHIBIT", "102", "FDA", "Conference", "Call", "on", "July", "31,", "2002", "TPNA", "Personnel:", "Wendell", "Cheatham,", "M.D.", "Vice", "President,", "of", "Medial", "and", "Scientific", "Affairs", "Michael", "Elisseou,", "Ph.D.,", "Dire...	[ [ 814, 80, 828, 107 ], [ 815, 45, 830, 79 ], [ 868, 41, 919, 53 ], [ 874, 63, 928, 88 ], [ 344, 134, 382, 150 ], [ 385, 134, 474, 150 ], [ 478, 135, 510, 150 ], [ 514, ...	What is the date mentioned at the bottom?	09/18/12
596	[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...	[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...	What is the heading of this document, given at the top?	Avandamet Uptake
596	[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...	[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...	What are shown on the x-axis?	FULL MONTHS POST LAUNCH
596	[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...	[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...	What is the percentage of Avandamet scripts from Actos mentioned?	36%
596	[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...	[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...	What is on the horizonal axis of the graph?	Full Months Post Launch
597	[ "Link", "between", "IR", "and", "CVD", "THE", "ROUTE", "TO", "CARDIOVASCULAR", "DISEASE", "2", "152", "13", "A", "Hyperglycemia..", "Insulin", "A", "Hyper", "Resistance", ".", ".", ".", "a", "path", "that", "leads", "to", "increased", "risk", "for", "MI", ...	[ [ 98, 105, 187, 152 ], [ 195, 104, 363, 153 ], [ 373, 104, 412, 153 ], [ 431, 104, 504, 153 ], [ 516, 105, 596, 153 ], [ 248, 279, 282, 302 ], [ 287, 279, 347, 303 ], [ 354...	Heading of the document?	LINK BETWEEN IR AND CVD
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the chief leader ?	MR. K SAITO
597	[ "Link", "between", "IR", "and", "CVD", "THE", "ROUTE", "TO", "CARDIOVASCULAR", "DISEASE", "2", "152", "13", "A", "Hyperglycemia..", "Insulin", "A", "Hyper", "Resistance", ".", ".", ".", "a", "path", "that", "leads", "to", "increased", "risk", "for", "MI", ...	[ [ 98, 105, 187, 152 ], [ 195, 104, 363, 153 ], [ 373, 104, 412, 153 ], [ 431, 104, 504, 153 ], [ 516, 105, 596, 153 ], [ 248, 279, 282, 302 ], [ 287, 279, 347, 303 ], [ 354...	What is the percentage of Nondiabetic patients with prior MI?	18.8%
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the responsible person for TPNA ?	Dr. C Thom
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	what is the name of the organization ?	ACTOS ISSUE ORGANIZATION
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the responsible person of TCI ?	MR. K SAITO
600	[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...	[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...	What is the Handwritten sentence on the top?	Row-Contract (as of 7/19/99)
600	[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...	[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...	What is the date mentioned?	JULY 19, 1999
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the first contact person of EuR&D ?	DR. P COLLETT
600	[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...	[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...	With whom is the discussion being held?	JIM HARPER
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the responsible person for EuR&D ?	DR. D ECKLAND
602	[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...	[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...	What is the date of randomisation?	05-11-01
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the first contact person of TPNA ?	MS. M RAMSTACK, MS. J HASKINS
602	[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...	[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...	What is the patient number?	014
602	[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...	[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...	What is the Centre number?	49013
598	[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...	[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...	who is the first contact person of TCI ?	MR. M MIYAZAKI
602	[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...	[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...	What is the Reference mentioned here?	135037-HRT-11
604	[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...	[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...	What is the heading of the table?	Weight Changes (kg) from Baseline during Double-Blind Clinical Trials with ACTOS
575	[ "Most", "Significant", "Adverse", "Events", "Risks", "for", "Pioglitazone", "Risk", "Onset", "Reversibility", "Clinical", "Findings", "Occurrence", "of", "ALT", "Elevation", "Within", "2", "months", "Only", "through", "Drug", "Placebo", "Liver", "Failure", "Transpla...	[ [ 246, 181, 293, 198 ], [ 297, 181, 392, 198 ], [ 396, 182, 469, 199 ], [ 473, 182, 534, 199 ], [ 538, 182, 588, 199 ], [ 593, 182, 618, 199 ], [ 622, 182, 735, 199 ], [ 25...	what is the total number of drug claims under the title of "summary of litigation risk in the ous territories"?	5
606	[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...	[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...	what are secondary endpoints ?	CARDIOVASCULAR MORTALITY
608	[ "Objectives", "and", "Methodology", "A.", "Objectives", "The", "primary", "objectives", "of", "these", "market", "research", "meetings", "were", "to", "1)", "Present", "new", "data", "regarding", "Type", "2", "diabetes", "in", "the", "context", "of", "insulin", ...	[ [ 168, 82, 287, 103 ], [ 292, 82, 334, 104 ], [ 339, 82, 487, 104 ], [ 120, 117, 142, 135 ], [ 170, 118, 276, 136 ], [ 170, 167, 203, 183 ], [ 210, 167, 278, 183 ], [ 285, ...	what is the title of this page?	OBJECTIVES AND METHODOLOGY
606	[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...	[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...	What is the number of patients ?	5,000
606	[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...	[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...	What is "FPV" ?	JUNE 2001
604	[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...	[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...	What is the ACTOS 15 mg of Monotherapy?	0.9(-0.5/3.4) N=79
604	[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...	[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...	What is the trial duration mentioned?	16 TO 26 WEEKS
610	[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...	[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...	what is the name of the form ?	URGENT DATA ENQUIRY FORM
610	[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...	[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...	what is the centre number ?	49013
604	[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...	[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...	What is the ACTOS 45 mg of Combination Therapy of Insulin?	4.1 (1.4/6.8) N=338
611	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...	[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...	What is the date mentioned?	August 12-13, 2002
610	[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...	[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...	what is the date issued mentioned in the form ?	22-04-04
610	[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...	[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...	what is the patient number ?	014
611	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...	[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...	What is the Item that shows Person Responsible Bob Ahlbrandt will send to John?	Add renal colic to clinical AE search
611	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...	[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...	What is the heading of the document?	TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING
611	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...	[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...	What is written just below the date?	Action Item List/Document Timelines
614	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...	[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...	What is the heading of the document?	TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING
614	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...	[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...	What is the date mentioned?	August 12-13, 2002
614	[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...	[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...	What is the heading of the handwritten words in Pediatric Indication?	Appendix
615	[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...	[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...	what is the patient number?	014
617	[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...	[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...	Which Procedures No is being decribed here?	Procedures No. 19
612	[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...	[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...	how many targeted primary care physicians are included in these meetings ?	350
617	[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...	[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...	What is Article 4 in this document referred to?	Disposal Record Ledger
612	[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...	[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...	in which month and year eight regional market research consultants meetings were held ?	October and November 2001
617	[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...	[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...	In which Article, Persons In Charge of Retention is described?	Article 2
615	[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...	[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...	what is diagnosis?	benign tumor of the urinary bladder
618	[ "There", "is", "generally", "broad", "acceptance", "of", "the", "lipid", "distinctions", "between", "ACTOS", "and", "Avandia,", "Participants", "are", "seeking", "clinical", "endpoint", "data", "comparing", "ACTOS", "to", "Avandia.", "There", "is", "broad", "gener...	[ [ 168, 93, 215, 109 ], [ 220, 93, 239, 109 ], [ 244, 93, 325, 109 ], [ 328, 93, 382, 109 ], [ 386, 93, 485, 109 ], [ 491, 93, 511, 109 ], [ 515, 93, 545, 109 ], [ 550, ...	what are the challenges of ACTOS positive data?	small numbers in the studies, non-randomized, company-sponsored.
631	[ "NDA", "21-073/5-023", "Page", "19", "Pediatric", "Use", "Safety", "and", "effectiveness", "of", "ACTOS", "in", "pediatric", "patients", "have", "not", "been", "established.", "Elderly", "Use", "Approximately", "500", "patients", "in", "placebo-controlled", "clinica...	[ [ 119, 61, 159, 77 ], [ 163, 61, 263, 77 ], [ 119, 79, 157, 93 ], [ 161, 79, 179, 93 ], [ 118, 108, 198, 122 ], [ 201, 108, 234, 122 ], [ 119, 125, 172, 138 ], [ 175, 1...	In U.S. clinical trials, how many patients have received ACTOS?	over 4700 patients
618	[ "There", "is", "generally", "broad", "acceptance", "of", "the", "lipid", "distinctions", "between", "ACTOS", "and", "Avandia,", "Participants", "are", "seeking", "clinical", "endpoint", "data", "comparing", "ACTOS", "to", "Avandia.", "There", "is", "broad", "gener...	[ [ 168, 93, 215, 109 ], [ 220, 93, 239, 109 ], [ 244, 93, 325, 109 ], [ 328, 93, 382, 109 ], [ 386, 93, 485, 109 ], [ 491, 93, 511, 109 ], [ 515, 93, 545, 109 ], [ 550, ...	What does alternate terms include?	core therapy; cornerstone therapy; first-line.
612	[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...	[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...	which is an effective and liver-safe agent accepted by the participants ?	ACTOS
612	[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...	[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...	what is an effective and trusted agent ?	Metformin
631	[ "NDA", "21-073/5-023", "Page", "19", "Pediatric", "Use", "Safety", "and", "effectiveness", "of", "ACTOS", "in", "pediatric", "patients", "have", "not", "been", "established.", "Elderly", "Use", "Approximately", "500", "patients", "in", "placebo-controlled", "clinica...	[ [ 119, 61, 159, 77 ], [ 163, 61, 263, 77 ], [ 119, 79, 157, 93 ], [ 161, 79, 179, 93 ], [ 118, 108, 198, 122 ], [ 201, 108, 234, 122 ], [ 119, 125, 172, 138 ], [ 175, 1...	Which medicine is used for treating type 2 diabetes in over 5900 patients?	ACTOS
612	[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...	[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...	what are the most commonly mentioned reasons not to prescribe TZD's ?	1) Cost, 2) Edema/weight gain, and 3) Reimbursement.
621	[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...	[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...	in one ACTOS treatment group how much amount of initial dose is given to the patients daily ?	7.5 mg
621	[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...	[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...	in a 24 week placebo controlled study how many patients with type 2 diabetes were randomized ?	260 patients
625	[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...	[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...	What is the retention time period of monthly reports?	30 years
621	[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...	[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...	in the second ACTOS treatment group,how much amount of initial dose patients should receive daily ?	15 mg
625	[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...	[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...	What does Attachment 1 describes?	List of Retention Periods of Time, Retention Locations
625	[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...	[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...	What is the retention time period of contracts?	Permanently
667	[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...	[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...	What is the date mentioned in this document?	March 2017
667	[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...	[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...	Who is the President of The Fertilizer Institute?	Chris Jahn
615	[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...	[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...	What is the exhibit number?	39
667	[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...	[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...	Roger Johnson is associated with which union?	National Farmers Union
667	[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...	[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...	What is the title of this document?	CEO Council Members
630	[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...	[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...	What is accepted as an effective glucose control agent?	ACTOS
630	[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...	[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...	what are reasons not to prescribe TZDs ?	1)cost,2)edema/weight gain, and 3) reimbursement
630	[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...	[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...	what is the subheading under the title of "specific findings"?	A. Reaction to IR Information
635	[ "ial", "Report", "12-13-01.doc", "DALY", "61", "ACTOS\"", "(pioglitazone", "HCI)", "Market", "Research", "Consultants", "Meetings", "\"Assessing", "TZD", "Effects", "Beyond", "Glycemic", "Control\"", "CTK-ACTLAP", "-", "Final", "Report", "-", "This", "report", "cont...	[ [ 137, 60, 159, 72 ], [ 162, 59, 221, 72 ], [ 224, 58, 328, 72 ], [ 755, 44, 853, 85 ], [ 862, 43, 908, 84 ], [ 302, 171, 410, 195 ], [ 414, 170, 580, 195 ], [ 585, 169...	What is the date mentioned?	December, 2001
635	[ "ial", "Report", "12-13-01.doc", "DALY", "61", "ACTOS\"", "(pioglitazone", "HCI)", "Market", "Research", "Consultants", "Meetings", "\"Assessing", "TZD", "Effects", "Beyond", "Glycemic", "Control\"", "CTK-ACTLAP", "-", "Final", "Report", "-", "This", "report", "cont...	[ [ 137, 60, 159, 72 ], [ 162, 59, 221, 72 ], [ 224, 58, 328, 72 ], [ 755, 44, 853, 85 ], [ 862, 43, 908, 84 ], [ 302, 171, 410, 195 ], [ 414, 170, 580, 195 ], [ 585, 169...	By whom was this document prepared?	C. Beck, LLC
639	[ "EPA'S", "PROPOSED", "CHEMICAL", "SAFETY", "RULES.", "CHEMICAL", "INDUSTRY", "COMMENTS", "AND", "EPA'S", "FINAL", "RULES", "PROPOSED", "RULE", "AMERICAN", "CHEMISTRY", "FINAL", "RULE,", "JAN.", "19,", "2017", "COUNCIL", "COMMENTS", "JUNE", "22,", "2017", "PRIORITI...	[ [ 146, 49, 216, 67 ], [ 224, 49, 364, 67 ], [ 376, 49, 511, 67 ], [ 517, 49, 620, 67 ], [ 625, 48, 719, 67 ], [ 723, 48, 857, 67 ], [ 197, 84, 331, 101 ], [ 337, 85, ...	When was the rule PROPOSED?	Jan. 19, 2017
645	[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...	[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...	What is the name of the FOUNDATION this PROPOSAL belongs to?	Toxicology Education Foundation
645	[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...	[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...	Who is the vice president of this FOUNDATION?	William Farland, PhD, ATS
645	[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...	[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...	What is the date mentioned at the bottom?	July 20th 2017
643	[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...	[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...	Whose biography is this?	Christopher Jahn
643	[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...	[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...	What is the full form of TFI?	The Fertilizer Institute
643	[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...	[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...	For how many years did Christopher Jahn work for U.S. Senator Craig Thomas?	10
643	[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...	[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...	What is the full form CSA?	Contract Services Association
641	[ "Developing", "the", "Safety", "Range", "for", "TCE", "*", "In", "the", "IRIS", "Summary", "for", "TCE,", "U.S.", "EPA", "identified", "three", "candidate", "RfC", "values", "from", "principal", "and", "supporting", "studies", "for", "the", "noncancer", "inhal...	[ [ 168, 100, 400, 163 ], [ 407, 101, 481, 163 ], [ 488, 101, 614, 163 ], [ 622, 100, 748, 162 ], [ 756, 100, 823, 159 ], [ 832, 99, 914, 157 ], [ 177, 228, 195, 264 ], [ 206...	Which number is lightly printed lower-right side of the document?	22
640	[ "Appendix", "A", "-", "Mode", "of", "Action", "Analysis", "for", "Liver", "Tumors", "Based", "on", "NCI", "Slide", "Reread", "and", "RfD", "Derivation", "(Dourson", "et", "al.", "2014)", "ACRONYMS", "AND", "ABBREVIATIONS", "BMD", "benchmark", "dose-modeling", ...	[ [ 116, 65, 185, 80 ], [ 188, 65, 201, 80 ], [ 204, 65, 210, 80 ], [ 214, 65, 257, 80 ], [ 260, 65, 274, 80 ], [ 278, 65, 324, 80 ], [ 328, 65, 389, 81 ], [ 392, 65, ...	what is in the appendix A?	mode of action analysis for liver tumors based on NCI slide reread and Rfd derivation (Dourson et al. 2014)
646	[ "BOARD", "OF", "TRUSTEES", "2016", "President", "Suzanne", "C.", "Fitzpatrick,", "PhD,", "DABT", "U.S.", "Food", "and", "Drug", "Administration", "Michael", "Leonard", "Dourson,", "PhD,", "DABT,", "ATS", "Toxicology", "Excellence", "for", "Risk", "Assessment", "St...	[ [ 347, 47, 428, 65 ], [ 437, 47, 471, 65 ], [ 477, 47, 598, 65 ], [ 605, 47, 657, 65 ], [ 60, 119, 141, 134 ], [ 541, 119, 609, 134 ], [ 612, 119, 631, 134 ], [ 634, 11...	What is the name of the President of BOARD OF TRUSTEES?	Michael Leonard Dourson
646	[ "BOARD", "OF", "TRUSTEES", "2016", "President", "Suzanne", "C.", "Fitzpatrick,", "PhD,", "DABT", "U.S.", "Food", "and", "Drug", "Administration", "Michael", "Leonard", "Dourson,", "PhD,", "DABT,", "ATS", "Toxicology", "Excellence", "for", "Risk", "Assessment", "St...	[ [ 347, 47, 428, 65 ], [ 437, 47, 471, 65 ], [ 477, 47, 598, 65 ], [ 605, 47, 657, 65 ], [ 60, 119, 141, 134 ], [ 541, 119, 609, 134 ], [ 612, 119, 631, 134 ], [ 634, 11...	To which university did William H. Farland belong to?	Colorado State University
642	[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...	[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...	What is the timing mentioned?	a one week turnaround, depending upon availability
642	[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...	[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...	What is the Total Project Cost?	56,400
642	[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...	[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...	What is the heading of the budget table?	For 5 Test Articles - Phase IB (definitive)
647	[ "Thank", "You", "MSECA", "Conference", "organizers,", "esp.", "Megan", "Hamilton", "and", "Brian", "Lewis", "#", "Panel", "Participants", "Alliance", "for", "Risk", "Assessment", "Publication", "co-authors", "Michael", "Dourson,", "Bernard", "Gadagbui,", "John", "Lo...	[ [ 181, 122, 385, 211 ], [ 401, 120, 508, 210 ], [ 258, 256, 394, 305 ], [ 259, 343, 472, 396 ], [ 483, 344, 682, 398 ], [ 689, 344, 758, 398 ], [ 764, 342, 879, 398 ], [ 25...	What is the heading of the document?	Thank You
647	[ "Thank", "You", "MSECA", "Conference", "organizers,", "esp.", "Megan", "Hamilton", "and", "Brian", "Lewis", "#", "Panel", "Participants", "Alliance", "for", "Risk", "Assessment", "Publication", "co-authors", "Michael", "Dourson,", "Bernard", "Gadagbui,", "John", "Lo...	[ [ 181, 122, 385, 211 ], [ 401, 120, 508, 210 ], [ 258, 256, 394, 305 ], [ 259, 343, 472, 396 ], [ 483, 344, 682, 398 ], [ 689, 344, 758, 398 ], [ 764, 342, 879, 398 ], [ 25...	Who are the Publication co-authors?	Michael Dourson, Bernard Gadagbui, John Lowe and Rod Thompson
650	[ "RESEARCH", "FOUNDATION", "NFPA", "RESEARCH", "FOR", "THE", "NFPA", "MISSION", "PPE", "Cleaning", "Validation", "Validation", "of", "Cleaning", "Procedures", "for", "Fire", "Fighter", "Personal", "Protective", "Equipment", "(PPE)", "PROJECT", "CONTACTS", "Last", "Up...	[ [ 330, 62, 574, 98 ], [ 588, 62, 880, 98 ], [ 122, 111, 197, 129 ], [ 328, 111, 446, 130 ], [ 452, 111, 498, 130 ], [ 502, 111, 544, 130 ], [ 548, 111, 605, 130 ], [ 610, ...	what is the full form of ppe?	Personal Protective Equipment
650	[ "RESEARCH", "FOUNDATION", "NFPA", "RESEARCH", "FOR", "THE", "NFPA", "MISSION", "PPE", "Cleaning", "Validation", "Validation", "of", "Cleaning", "Procedures", "for", "Fire", "Fighter", "Personal", "Protective", "Equipment", "(PPE)", "PROJECT", "CONTACTS", "Last", "Up...	[ [ 330, 62, 574, 98 ], [ 588, 62, 880, 98 ], [ 122, 111, 197, 129 ], [ 328, 111, 446, 130 ], [ 452, 111, 498, 130 ], [ 502, 111, 544, 130 ], [ 548, 111, 605, 130 ], [ 610, ...	what is the subtitle for research foundation?	Research for the NFPA Mission

544

[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...

[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...

What is the Specific example given?

pioglitazone: need to commit to studies to investigate certain signals

588

[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...

[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...

what is the month and year of overview of submission ?

NOVEMBER 2006

544

[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...

[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...

Which country would have similar interest as in Europe?

usa

588

[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...

[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...

what is included in the summary document ?

includes benefit-risk assessment

544

[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...

[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...

What is the Suggestion from Glyn?

tgrd would formulate direct risk management plan and obtain japan's input

588

[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...

[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...

what is the executive summary of bladder cancer cases ?

CONFIRM

544

[ "4)", "Marketing", ">", "6", "monthly", "PSUR's", ".", "In", "the", "future,", "risk", "management", "plan", "will", "be", "reviewed", "to", "see", "how", "much", "of", "the", "safety", "signals", "have", "been", "clarified.", "Will", "include", "not", "ju...

[ [ 222, 147, 241, 161 ], [ 244, 147, 314, 161 ], [ 317, 148, 328, 161 ], [ 332, 148, 340, 161 ], [ 343, 148, 397, 161 ], [ 400, 148, 453, 162 ], [ 457, 148, 461, 162 ], [ 46...

Full form of PEM?

prescription event monitoring

588

[ "Overview", "of", "November", "2006", "Submission", "o", "Partial", "clinical", "hold", "removal", "request", "document:", "Summary", "document", "(Includes", "benefit-", "risk", "assessment)", "Meta-analysis", "report", "Kaiser", "first", "cohort", "report", "New", ...

[ [ 194, 130, 376, 182 ], [ 396, 130, 438, 182 ], [ 445, 130, 663, 182 ], [ 670, 130, 768, 181 ], [ 196, 200, 426, 253 ], [ 193, 309, 216, 352 ], [ 225, 309, 351, 353 ], [ 35...

what is the name of the request document ?

PARTIAL CLINICAL HOLD REMOVAL REQUEST DOCUMENT

545

[ "PENGAD", "BOO-631-698", "EXHIBIT", "102", "FDA", "Conference", "Call", "on", "July", "31,", "2002", "TPNA", "Personnel:", "Wendell", "Cheatham,", "M.D.", "Vice", "President,", "of", "Medial", "and", "Scientific", "Affairs", "Michael", "Elisseou,", "Ph.D.,", "Dire...

[ [ 814, 80, 828, 107 ], [ 815, 45, 830, 79 ], [ 868, 41, 919, 53 ], [ 874, 63, 928, 88 ], [ 344, 134, 382, 150 ], [ 385, 134, 474, 150 ], [ 478, 135, 510, 150 ], [ 514, ...

On the purpose of teleconference, how many topics were to be discussed?

3

545

[ "PENGAD", "BOO-631-698", "EXHIBIT", "102", "FDA", "Conference", "Call", "on", "July", "31,", "2002", "TPNA", "Personnel:", "Wendell", "Cheatham,", "M.D.", "Vice", "President,", "of", "Medial", "and", "Scientific", "Affairs", "Michael", "Elisseou,", "Ph.D.,", "Dire...

[ [ 814, 80, 828, 107 ], [ 815, 45, 830, 79 ], [ 868, 41, 919, 53 ], [ 874, 63, 928, 88 ], [ 344, 134, 382, 150 ], [ 385, 134, 474, 150 ], [ 478, 135, 510, 150 ], [ 514, ...

What is the date mentioned at the bottom?

09/18/12

596

[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...

[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...

What is the heading of this document, given at the top?

Avandamet Uptake

596

[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...

[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...

What are shown on the x-axis?

FULL MONTHS POST LAUNCH

596

[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...

[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...

What is the percentage of Avandamet scripts from Actos mentioned?

36%

596

[ "Avandamet", "Uptake", "Retail", "TRx", "(000s),", "IMS", "Health", "TRX", "(000s)", "Assumes", "36%", "of", "Avandamet", "scripts", "from", "Actos", "500", "Glucovance", "450", "400", "*", "350", "Avandamet", "300", "Forecast", "250", "200", "150", "100", "...

[ [ 100, 90, 303, 136 ], [ 308, 89, 432, 141 ], [ 107, 164, 156, 189 ], [ 159, 164, 194, 189 ], [ 197, 164, 256, 189 ], [ 259, 164, 294, 189 ], [ 297, 164, 352, 189 ], [ 105,...

What is on the horizonal axis of the graph?

Full Months Post Launch

597

[ "Link", "between", "IR", "and", "CVD", "THE", "ROUTE", "TO", "CARDIOVASCULAR", "DISEASE", "2", "152", "13", "A", "Hyperglycemia..", "Insulin", "A", "Hyper", "Resistance", ".", ".", ".", "a", "path", "that", "leads", "to", "increased", "risk", "for", "MI", ...

[ [ 98, 105, 187, 152 ], [ 195, 104, 363, 153 ], [ 373, 104, 412, 153 ], [ 431, 104, 504, 153 ], [ 516, 105, 596, 153 ], [ 248, 279, 282, 302 ], [ 287, 279, 347, 303 ], [ 354...

Heading of the document?

LINK BETWEEN IR AND CVD

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the chief leader ?

MR. K SAITO

597

[ "Link", "between", "IR", "and", "CVD", "THE", "ROUTE", "TO", "CARDIOVASCULAR", "DISEASE", "2", "152", "13", "A", "Hyperglycemia..", "Insulin", "A", "Hyper", "Resistance", ".", ".", ".", "a", "path", "that", "leads", "to", "increased", "risk", "for", "MI", ...

[ [ 98, 105, 187, 152 ], [ 195, 104, 363, 153 ], [ 373, 104, 412, 153 ], [ 431, 104, 504, 153 ], [ 516, 105, 596, 153 ], [ 248, 279, 282, 302 ], [ 287, 279, 347, 303 ], [ 354...

What is the percentage of Nondiabetic patients with prior MI?

18.8%

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the responsible person for TPNA ?

Dr. C Thom

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

what is the name of the organization ?

ACTOS ISSUE ORGANIZATION

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the responsible person of TCI ?

MR. K SAITO

600

[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...

[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...

What is the Handwritten sentence on the top?

Row-Contract (as of 7/19/99)

600

[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...

[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...

What is the date mentioned?

JULY 19, 1999

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the first contact person of EuR&D ?

DR. P COLLETT

600

[ "ENGAD", "800-631-6989", "EXHIBIT", "ROW-", "Contract", "(", "av", "of", "7/19/", "99)", "81", "Project", "Cat", "Update", "Discussion", "with", "Jim", "Harper", "July", "19,", "1999", "Agenda", "1", "Status", "of", "negotiations", "with", "Takeda", "1", "Re...

[ [ 795, 100, 812, 122 ], [ 794, 58, 810, 99 ], [ 844, 54, 896, 69 ], [ 185, 69, 308, 125 ], [ 321, 69, 468, 125 ], [ 479, 71, 481, 125 ], [ 492, 71, 518, 125 ], [ 529, 7...

With whom is the discussion being held?

JIM HARPER

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the responsible person for EuR&D ?

DR. D ECKLAND

602

[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...

[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...

What is the date of randomisation?

05-11-01

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the first contact person of TPNA ?

MS. M RAMSTACK, MS. J HASKINS

602

[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...

[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...

What is the patient number?

014

602

[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...

[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...

What is the Centre number?

49013

598

[ "Actos", "Issue", "Organization", "Chief", "leader", ":", "Mr.", "K", "Saito", ".", "Responsible", "persons", "-", "TPNA", ":", "Dr.", "C", "Thom", "-", "EuR", "&D", ":", "Dr.", "D", "Eckland", "-", "TCI", ":", "Mr.", "K", "Saito", ".", "First", "con...

[ [ 213, 42, 343, 79 ], [ 352, 42, 473, 81 ], [ 485, 39, 791, 82 ], [ 123, 105, 231, 136 ], [ 236, 105, 362, 137 ], [ 377, 105, 396, 137 ], [ 403, 105, 483, 137 ], [ 490, ...

who is the first contact person of TCI ?

MR. M MIYAZAKI

602

[ "04/05/2004", "11:05", "22434/2084", "12:0", "49-931-20136759", "NORL", "*", "9004993123136283", "DIABETESAMBULANZ", "S.", "02/03", "NO.", "938", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "Patient", "initials", "Date", ...

[ [ 172, 176, 239, 185 ], [ 251, 176, 279, 186 ], [ 162, 186, 229, 195 ], [ 252, 187, 277, 194 ], [ 310, 178, 404, 189 ], [ 312, 187, 340, 197 ], [ 345, 188, 354, 198 ], [ 35...

What is the Reference mentioned here?

135037-HRT-11

604

[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...

[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...

What is the heading of the table?

Weight Changes (kg) from Baseline during Double-Blind Clinical Trials with ACTOS

575

[ "Most", "Significant", "Adverse", "Events", "Risks", "for", "Pioglitazone", "Risk", "Onset", "Reversibility", "Clinical", "Findings", "Occurrence", "of", "ALT", "Elevation", "Within", "2", "months", "Only", "through", "Drug", "Placebo", "Liver", "Failure", "Transpla...

[ [ 246, 181, 293, 198 ], [ 297, 181, 392, 198 ], [ 396, 182, 469, 199 ], [ 473, 182, 534, 199 ], [ 538, 182, 588, 199 ], [ 593, 182, 618, 199 ], [ 622, 182, 735, 199 ], [ 25...

what is the total number of drug claims under the title of "summary of litigation risk in the ous territories"?

5

606

[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...

[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...

what are secondary endpoints ?

CARDIOVASCULAR MORTALITY

608

[ "Objectives", "and", "Methodology", "A.", "Objectives", "The", "primary", "objectives", "of", "these", "market", "research", "meetings", "were", "to", "1)", "Present", "new", "data", "regarding", "Type", "2", "diabetes", "in", "the", "context", "of", "insulin", ...

[ [ 168, 82, 287, 103 ], [ 292, 82, 334, 104 ], [ 339, 82, 487, 104 ], [ 120, 117, 142, 135 ], [ 170, 118, 276, 136 ], [ 170, 167, 203, 183 ], [ 210, 167, 278, 183 ], [ 285, ...

what is the title of this page?

OBJECTIVES AND METHODOLOGY

606

[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...

[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...

What is the number of patients ?

5,000

606

[ "PROactive", "Objective:", "Demonstrate", "that", "pioglitazone", "reduces", "total", "mortality", "and", "macrovascular", "morbidity", "in", "high-risk", "patients", "with", "type", "2", "diabetes", "mellitus", "Number", "of", "patients:", "5,000", "Countries:", "Aus...

[ [ 85, 136, 287, 187 ], [ 132, 273, 236, 299 ], [ 374, 278, 496, 305 ], [ 502, 278, 540, 305 ], [ 543, 278, 657, 305 ], [ 661, 278, 741, 305 ], [ 745, 278, 785, 302 ], [ 372...

What is "FPV" ?

JUNE 2001

604

[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...

[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...

What is the ACTOS 15 mg of Monotherapy?

0.9(-0.5/3.4) N=79

604

[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...

[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...

What is the trial duration mentioned?

16 TO 26 WEEKS

610

[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...

[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...

what is the name of the form ?

URGENT DATA ENQUIRY FORM

610

[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...

[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...

what is the centre number ?

49013

604

[ "NDA", "21-073/8-023", "Page", "13", "in", "insulin", "combination", "studies,", "a", "small", "number", "of", "patients", "with", "a", "history", "of", "previously", "existing", "cardiac", "disease", "developed", "congestive", "heart", "failure", "when", "treated...

[ [ 114, 61, 155, 76 ], [ 159, 61, 259, 76 ], [ 115, 78, 153, 92 ], [ 156, 78, 169, 92 ], [ 115, 107, 130, 121 ], [ 133, 107, 188, 121 ], [ 191, 108, 291, 122 ], [ 293, 1...

What is the ACTOS 45 mg of Combination Therapy of Insulin?

4.1 (1.4/6.8) N=338

611

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...

[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...

What is the date mentioned?

August 12-13, 2002

610

[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...

[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...

what is the date issued mentioned in the form ?

22-04-04

610

[ "84/05/2004", "11:05", "49", "931", "20136759", "32/04/2004", "19-931-20136759", "12:03", "NCRL", "+", "9004993129136283", "DIABETESAMBULANZ", "01/03", "NO.", "938", "0302", "PROactive", "Urgent", "Data", "Enquiry", "Form", "Centre", "number", "Patient", "number", "...

[ [ 152, 188, 218, 198 ], [ 229, 190, 261, 199 ], [ 300, 182, 315, 191 ], [ 320, 182, 341, 191 ], [ 345, 182, 393, 192 ], [ 142, 199, 207, 208 ], [ 289, 192, 382, 201 ], [ 23...

what is the patient number ?

014

611

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...

[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...

What is the Item that shows Person Responsible Bob Ahlbrandt will send to John?

Add renal colic to clinical AE search

611

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...

[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...

What is the heading of the document?

TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING

611

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "TAK-THOMCL-00017303", "Produced", "in", "MDL", "on", "09/14/12", "Action", "Item", "List/Document", "Timelines", "Item", "Person", "Responsible", "Create", "table", "summarizing", "medium", ...

[ [ 95, 143, 255, 168 ], [ 259, 144, 319, 168 ], [ 322, 144, 412, 168 ], [ 415, 143, 493, 168 ], [ 238, 171, 280, 188 ], [ 283, 171, 322, 188 ], [ 324, 171, 352, 188 ], [ 567...

What is written just below the date?

Action Item List/Document Timelines

614

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...

[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...

What is the heading of the document?

TPNA/TEUR&D/TCI ACTOS RESPONSE MEETING

614

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...

[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...

What is the date mentioned?

August 12-13, 2002

614

[ "TPNA/TEUR&D/TCI", "ACTOS", "RESPONSE", "MEETING", "August", "12-13,", "2002", "FDA", "Response", "Outline", "LABEL", "CHANGE", "CLINICAL", "PEDIATRIC", "INDICATION", "Current", "label", "adequately", "reflects", "General", "epidemiology", "of", "bladder", "We", "beli...

[ [ 223, 42, 428, 63 ], [ 433, 43, 510, 62 ], [ 515, 43, 633, 62 ], [ 638, 42, 741, 61 ], [ 407, 65, 461, 78 ], [ 463, 65, 514, 79 ], [ 516, 64, 553, 79 ], [ 373, 87, ...

What is the heading of the handwritten words in Pediatric Indication?

Appendix

615

[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...

[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...

what is the patient number?

014

617

[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...

[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...

Which Procedures No is being decribed here?

Procedures No. 19

612

[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...

[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...

how many targeted primary care physicians are included in these meetings ?

350

617

[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...

[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...

What is Article 4 in this document referred to?

Disposal Record Ledger

612

[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...

[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...

in which month and year eight regional market research consultants meetings were held ?

October and November 2001

617

[ "Translation", "of", "TAKJ-TPC-00000431", "Procedures", "Regarding", "Document", "Control", "Research.", "Div.", "Procedures", "No.", "19", "Article", "1", "(Purpose)", "These", "procedures", "make", "stipulations", "about", "the", "retention", "and", "disposal", "of"...

[ [ 377, 139, 457, 153 ], [ 460, 139, 478, 152 ], [ 481, 137, 637, 153 ], [ 249, 177, 328, 191 ], [ 331, 178, 407, 191 ], [ 410, 177, 487, 191 ], [ 490, 177, 547, 191 ], [ 69...

In which Article, Persons In Charge of Retention is described?

Article 2

615

[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...

[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...

what is diagnosis?

benign tumor of the urinary bladder

618

[ "There", "is", "generally", "broad", "acceptance", "of", "the", "lipid", "distinctions", "between", "ACTOS", "and", "Avandia,", "Participants", "are", "seeking", "clinical", "endpoint", "data", "comparing", "ACTOS", "to", "Avandia.", "There", "is", "broad", "gener...

[ [ 168, 93, 215, 109 ], [ 220, 93, 239, 109 ], [ 244, 93, 325, 109 ], [ 328, 93, 382, 109 ], [ 386, 93, 485, 109 ], [ 491, 93, 511, 109 ], [ 515, 93, 545, 109 ], [ 550, ...

what are the challenges of ACTOS positive data?

small numbers in the studies, non-randomized, company-sponsored.

631

[ "NDA", "21-073/5-023", "Page", "19", "Pediatric", "Use", "Safety", "and", "effectiveness", "of", "ACTOS", "in", "pediatric", "patients", "have", "not", "been", "established.", "Elderly", "Use", "Approximately", "500", "patients", "in", "placebo-controlled", "clinica...

[ [ 119, 61, 159, 77 ], [ 163, 61, 263, 77 ], [ 119, 79, 157, 93 ], [ 161, 79, 179, 93 ], [ 118, 108, 198, 122 ], [ 201, 108, 234, 122 ], [ 119, 125, 172, 138 ], [ 175, 1...

In U.S. clinical trials, how many patients have received ACTOS?

over 4700 patients

618

[ "There", "is", "generally", "broad", "acceptance", "of", "the", "lipid", "distinctions", "between", "ACTOS", "and", "Avandia,", "Participants", "are", "seeking", "clinical", "endpoint", "data", "comparing", "ACTOS", "to", "Avandia.", "There", "is", "broad", "gener...

[ [ 168, 93, 215, 109 ], [ 220, 93, 239, 109 ], [ 244, 93, 325, 109 ], [ 328, 93, 382, 109 ], [ 386, 93, 485, 109 ], [ 491, 93, 511, 109 ], [ 515, 93, 545, 109 ], [ 550, ...

What does alternate terms include?

core therapy; cornerstone therapy; first-line.

612

[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...

[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...

which is an effective and liver-safe agent accepted by the participants ?

ACTOS

612

[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...

[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...

what is an effective and trusted agent ?

Metformin

631

[ "NDA", "21-073/5-023", "Page", "19", "Pediatric", "Use", "Safety", "and", "effectiveness", "of", "ACTOS", "in", "pediatric", "patients", "have", "not", "been", "established.", "Elderly", "Use", "Approximately", "500", "patients", "in", "placebo-controlled", "clinica...

[ [ 119, 61, 159, 77 ], [ 163, 61, 263, 77 ], [ 119, 79, 157, 93 ], [ 161, 79, 179, 93 ], [ 118, 108, 198, 122 ], [ 201, 108, 234, 122 ], [ 119, 125, 172, 138 ], [ 175, 1...

Which medicine is used for treating type 2 diabetes in over 5900 patients?

ACTOS

612

[ "Top-Line", "Summary", "Eight", "Regional", "Market", "Research", "Consultants", "Meetings", "were", "held", "in", "October", "and", "November", "2001.", "Each", "location", "featured", "the", "same", "program:", "1)", "A", "3-hour", "plenary", "session", "featuri...

[ [ 171, 60, 270, 83 ], [ 275, 62, 382, 83 ], [ 195, 92, 242, 108 ], [ 245, 92, 320, 108 ], [ 324, 93, 383, 108 ], [ 387, 93, 467, 108 ], [ 470, 93, 575, 107 ], [ 579, 93...

what are the most commonly mentioned reasons not to prescribe TZD's ?

1) Cost, 2) Edema/weight gain, and 3) Reimbursement.

621

[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...

[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...

in one ACTOS treatment group how much amount of initial dose is given to the patients daily ?

7.5 mg

621

[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...

[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...

in a 24 week placebo controlled study how many patients with type 2 diabetes were randomized ?

260 patients

625

[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...

[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...

What is the retention time period of monthly reports?

30 years

621

[ "NDA", "21-073/S-023", "Page", "10", "Table", "3", "Glycemic", "Parameters", "in", "a", "26-Week", "Placebo-Controlled", "Dose-Ranging", "Study", "ACTOS", "ACTOS", "ACTOS", "Placebo", "15", "mg", "30", "mg", "45", "mg", "Once", "Once", "Once", "Daily", "Daily"...

[ [ 111, 62, 150, 77 ], [ 155, 62, 254, 77 ], [ 110, 78, 149, 93 ], [ 152, 80, 169, 93 ], [ 120, 122, 165, 135 ], [ 168, 123, 178, 135 ], [ 304, 122, 378, 137 ], [ 382, 1...

in the second ACTOS treatment group,how much amount of initial dose patients should receive daily ?

15 mg

625

[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...

[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...

What does Attachment 1 describes?

List of Retention Periods of Time, Retention Locations

625

[ "Attachment", "1", "List", "of", "Retention", "Periods", "of", "Time.", "Retention", "Locations", "assification", "Type", "of", "Document", "Retention", "Time", "Period", "Retention", "Location", "Remarks", "Technical", "Experiment", "Notes,", "etc.", "30", "years",...

[ [ 162, 137, 247, 151 ], [ 250, 137, 257, 151 ], [ 299, 168, 330, 182 ], [ 332, 168, 350, 182 ], [ 353, 169, 427, 183 ], [ 430, 169, 488, 183 ], [ 492, 169, 510, 183 ], [ 51...

What is the retention time period of contracts?

Permanently

667

[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...

[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...

What is the date mentioned in this document?

March 2017

667

[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...

[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...

Who is the President of The Fertilizer Institute?

Chris Jahn

615

[ "0", "6", "MAY", "2004", "15778-001", "415778", "PROactive", "event", "description:", "part", "1", "Centre", "number", "Patientinitials", "Patient", "number", "Reason", "for", "alert", "report:", "(Heh", "all", "that", "apply)", "Complete", "pages", "out", "and"...

[ [ 228, 126, 237, 139 ], [ 240, 126, 250, 139 ], [ 252, 126, 284, 139 ], [ 287, 126, 311, 139 ], [ 595, 141, 672, 150 ], [ 424, 178, 486, 190 ], [ 203, 193, 364, 213 ], [ 56...

What is the exhibit number?

39

667

[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...

[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...

Roger Johnson is associated with which union?

National Farmers Union

667

[ "CEO", "Council", "Members", "American", "Farm", "Bureau", "Vincent", "\"Zippy\"", "Duvall,", "President", "American", "Seed", "Trade", "Association", "Andrew", "\"Andy\"", "LaVigne,", "President", "and", "CEO", "American", "Soybean", "Association", "Steve", "Censky,"...

[ [ 417, 135, 445, 151 ], [ 449, 136, 504, 152 ], [ 507, 136, 578, 152 ], [ 118, 173, 189, 186 ], [ 192, 174, 227, 187 ], [ 234, 173, 291, 187 ], [ 531, 173, 587, 187 ], [ 58...

What is the title of this document?

CEO Council Members

630

[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...

[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...

What is accepted as an effective glucose control agent?

ACTOS

630

[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...

[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...

what are reasons not to prescribe TZDs ?

1)cost,2)edema/weight gain, and 3) reimbursement

630

[ "Specific", "Findings", "A.", "Reaction", "to", "IR", "Information", "Participants", "accept", "ACTOS", "as", "an", "effective", "glucose", "control", "agent,", "and", "as", "a", "drug", "free", "of", "liver", "toxicity.", "If", "convinced", "by", "compelling", ...

[ [ 160, 83, 251, 102 ], [ 255, 83, 354, 103 ], [ 112, 117, 134, 134 ], [ 165, 118, 252, 135 ], [ 257, 118, 277, 135 ], [ 281, 118, 302, 135 ], [ 306, 118, 422, 137 ], [ 163,...

what is the subheading under the title of "specific findings"?

A. Reaction to IR Information

635

[ "ial", "Report", "12-13-01.doc", "DALY", "61", "ACTOS\"", "(pioglitazone", "HCI)", "Market", "Research", "Consultants", "Meetings", "\"Assessing", "TZD", "Effects", "Beyond", "Glycemic", "Control\"", "CTK-ACTLAP", "-", "Final", "Report", "-", "This", "report", "cont...

[ [ 137, 60, 159, 72 ], [ 162, 59, 221, 72 ], [ 224, 58, 328, 72 ], [ 755, 44, 853, 85 ], [ 862, 43, 908, 84 ], [ 302, 171, 410, 195 ], [ 414, 170, 580, 195 ], [ 585, 169...

What is the date mentioned?

December, 2001

635

[ "ial", "Report", "12-13-01.doc", "DALY", "61", "ACTOS\"", "(pioglitazone", "HCI)", "Market", "Research", "Consultants", "Meetings", "\"Assessing", "TZD", "Effects", "Beyond", "Glycemic", "Control\"", "CTK-ACTLAP", "-", "Final", "Report", "-", "This", "report", "cont...

[ [ 137, 60, 159, 72 ], [ 162, 59, 221, 72 ], [ 224, 58, 328, 72 ], [ 755, 44, 853, 85 ], [ 862, 43, 908, 84 ], [ 302, 171, 410, 195 ], [ 414, 170, 580, 195 ], [ 585, 169...

By whom was this document prepared?

C. Beck, LLC

639

[ "EPA'S", "PROPOSED", "CHEMICAL", "SAFETY", "RULES.", "CHEMICAL", "INDUSTRY", "COMMENTS", "AND", "EPA'S", "FINAL", "RULES", "PROPOSED", "RULE", "AMERICAN", "CHEMISTRY", "FINAL", "RULE,", "JAN.", "19,", "2017", "COUNCIL", "COMMENTS", "JUNE", "22,", "2017", "PRIORITI...

[ [ 146, 49, 216, 67 ], [ 224, 49, 364, 67 ], [ 376, 49, 511, 67 ], [ 517, 49, 620, 67 ], [ 625, 48, 719, 67 ], [ 723, 48, 857, 67 ], [ 197, 84, 331, 101 ], [ 337, 85, ...

When was the rule PROPOSED?

Jan. 19, 2017

645

[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...

[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...

What is the name of the FOUNDATION this PROPOSAL belongs to?

Toxicology Education Foundation

645

[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...

[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...

Who is the vice president of this FOUNDATION?

William Farland, PhD, ATS

645

[ "Toxicology", "Education", "Foundation", "page", "2", "-", "Proposal", "to", "3M", "from", "the", "Toxicology", "Education", "Foundation", "(TEF)", "Toxicology", "Education", "Foundation", "F.O.", "Box", "98224", "ESTIMATED", "DATE", "OF", "COMPLETION:", "It", "is...

[ [ 132, 46, 257, 65 ], [ 131, 64, 250, 80 ], [ 130, 80, 265, 96 ], [ 307, 85, 348, 100 ], [ 351, 85, 361, 100 ], [ 364, 85, 378, 100 ], [ 381, 84, 457, 100 ], [ 460, 84,...

What is the date mentioned at the bottom?

July 20th 2017

643

[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...

[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...

Whose biography is this?

Christopher Jahn

643

[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...

[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...

What is the full form of TFI?

The Fertilizer Institute

643

[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...

[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...

For how many years did Christopher Jahn work for U.S. Senator Craig Thomas?

10

643

[ "The", "Fertilizer", "Institute", "Nourish,", "Replenish,", "Grow", "BIOGRAPHY", "OF", "CHRISTOPHER", "JAHN", "President", "The", "Fertilizer", "Institute", "and", "the", "Nutrients", "for", "Life", "Foundation", "Christopher", "L.", "Jahn", "is", "president", "of",...

[ [ 147, 40, 187, 58 ], [ 115, 54, 303, 88 ], [ 310, 54, 484, 89 ], [ 113, 91, 194, 110 ], [ 199, 91, 296, 110 ], [ 300, 92, 352, 110 ], [ 288, 156, 431, 172 ], [ 437, 15...

What is the full form CSA?

Contract Services Association

641

[ "Developing", "the", "Safety", "Range", "for", "TCE", "*", "In", "the", "IRIS", "Summary", "for", "TCE,", "U.S.", "EPA", "identified", "three", "candidate", "RfC", "values", "from", "principal", "and", "supporting", "studies", "for", "the", "noncancer", "inhal...

[ [ 168, 100, 400, 163 ], [ 407, 101, 481, 163 ], [ 488, 101, 614, 163 ], [ 622, 100, 748, 162 ], [ 756, 100, 823, 159 ], [ 832, 99, 914, 157 ], [ 177, 228, 195, 264 ], [ 206...

Which number is lightly printed lower-right side of the document?

22

640

[ "Appendix", "A", "-", "Mode", "of", "Action", "Analysis", "for", "Liver", "Tumors", "Based", "on", "NCI", "Slide", "Reread", "and", "RfD", "Derivation", "(Dourson", "et", "al.", "2014)", "ACRONYMS", "AND", "ABBREVIATIONS", "BMD", "benchmark", "dose-modeling", ...

[ [ 116, 65, 185, 80 ], [ 188, 65, 201, 80 ], [ 204, 65, 210, 80 ], [ 214, 65, 257, 80 ], [ 260, 65, 274, 80 ], [ 278, 65, 324, 80 ], [ 328, 65, 389, 81 ], [ 392, 65, ...

what is in the appendix A?

mode of action analysis for liver tumors based on NCI slide reread and Rfd derivation (Dourson et al. 2014)

646

[ "BOARD", "OF", "TRUSTEES", "2016", "President", "Suzanne", "C.", "Fitzpatrick,", "PhD,", "DABT", "U.S.", "Food", "and", "Drug", "Administration", "Michael", "Leonard", "Dourson,", "PhD,", "DABT,", "ATS", "Toxicology", "Excellence", "for", "Risk", "Assessment", "St...

[ [ 347, 47, 428, 65 ], [ 437, 47, 471, 65 ], [ 477, 47, 598, 65 ], [ 605, 47, 657, 65 ], [ 60, 119, 141, 134 ], [ 541, 119, 609, 134 ], [ 612, 119, 631, 134 ], [ 634, 11...

What is the name of the President of BOARD OF TRUSTEES?

Michael Leonard Dourson

646

[ "BOARD", "OF", "TRUSTEES", "2016", "President", "Suzanne", "C.", "Fitzpatrick,", "PhD,", "DABT", "U.S.", "Food", "and", "Drug", "Administration", "Michael", "Leonard", "Dourson,", "PhD,", "DABT,", "ATS", "Toxicology", "Excellence", "for", "Risk", "Assessment", "St...

[ [ 347, 47, 428, 65 ], [ 437, 47, 471, 65 ], [ 477, 47, 598, 65 ], [ 605, 47, 657, 65 ], [ 60, 119, 141, 134 ], [ 541, 119, 609, 134 ], [ 612, 119, 631, 134 ], [ 634, 11...

To which university did William H. Farland belong to?

Colorado State University

642

[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...

[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...

What is the timing mentioned?

a one week turnaround, depending upon availability

642

[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...

[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...

What is the Total Project Cost?

56,400

642

[ "Budget:", ".......", "For", "5", "Test", "Articles", ".", "Phase", "18", "(definitive)", "Assay", "S/test", "Article", "Total", "Cost", "Combustion", "set", "up", "and", "collection", "3,000", "15,800", "Analytical", "chemistry", "on", "the", "above", "2,600", ...

[ [ 147, 129, 212, 143 ], [ 234, 188, 258, 196 ], [ 383, 196, 405, 206 ], [ 407, 196, 415, 206 ], [ 419, 196, 446, 206 ], [ 448, 195, 495, 206 ], [ 498, 195, 504, 206 ], [ 50...

What is the heading of the budget table?

For 5 Test Articles - Phase IB (definitive)

647

[ "Thank", "You", "MSECA", "Conference", "organizers,", "esp.", "Megan", "Hamilton", "and", "Brian", "Lewis", "#", "Panel", "Participants", "Alliance", "for", "Risk", "Assessment", "Publication", "co-authors", "Michael", "Dourson,", "Bernard", "Gadagbui,", "John", "Lo...

[ [ 181, 122, 385, 211 ], [ 401, 120, 508, 210 ], [ 258, 256, 394, 305 ], [ 259, 343, 472, 396 ], [ 483, 344, 682, 398 ], [ 689, 344, 758, 398 ], [ 764, 342, 879, 398 ], [ 25...

What is the heading of the document?

Thank You

647

[ "Thank", "You", "MSECA", "Conference", "organizers,", "esp.", "Megan", "Hamilton", "and", "Brian", "Lewis", "#", "Panel", "Participants", "Alliance", "for", "Risk", "Assessment", "Publication", "co-authors", "Michael", "Dourson,", "Bernard", "Gadagbui,", "John", "Lo...

[ [ 181, 122, 385, 211 ], [ 401, 120, 508, 210 ], [ 258, 256, 394, 305 ], [ 259, 343, 472, 396 ], [ 483, 344, 682, 398 ], [ 689, 344, 758, 398 ], [ 764, 342, 879, 398 ], [ 25...

Who are the Publication co-authors?

Michael Dourson, Bernard Gadagbui, John Lowe and Rod Thompson

650

[ "RESEARCH", "FOUNDATION", "NFPA", "RESEARCH", "FOR", "THE", "NFPA", "MISSION", "PPE", "Cleaning", "Validation", "Validation", "of", "Cleaning", "Procedures", "for", "Fire", "Fighter", "Personal", "Protective", "Equipment", "(PPE)", "PROJECT", "CONTACTS", "Last", "Up...

[ [ 330, 62, 574, 98 ], [ 588, 62, 880, 98 ], [ 122, 111, 197, 129 ], [ 328, 111, 446, 130 ], [ 452, 111, 498, 130 ], [ 502, 111, 544, 130 ], [ 548, 111, 605, 130 ], [ 610, ...

what is the full form of ppe?

Personal Protective Equipment

650

[ "RESEARCH", "FOUNDATION", "NFPA", "RESEARCH", "FOR", "THE", "NFPA", "MISSION", "PPE", "Cleaning", "Validation", "Validation", "of", "Cleaning", "Procedures", "for", "Fire", "Fighter", "Personal", "Protective", "Equipment", "(PPE)", "PROJECT", "CONTACTS", "Last", "Up...

[ [ 330, 62, 574, 98 ], [ 588, 62, 880, 98 ], [ 122, 111, 197, 129 ], [ 328, 111, 446, 130 ], [ 452, 111, 498, 130 ], [ 502, 111, 544, 130 ], [ 548, 111, 605, 130 ], [ 610, ...

what is the subtitle for research foundation?

Research for the NFPA Mission